This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Lab21, Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Carol Holland-Staley: Innovator in Hepatitis C Research
Introduction
Carol Holland-Staley is a prominent inventor based in Troy, MI (US). She has made significant contributions to the field of medical research, particularly in the identification and characterization of hepatitis C. Her innovative work has led to the development of novel methods and compositions that enhance the understanding of this virus.
Latest Patents
Carol Holland-Staley holds a patent for "Methods and compositions for identifying and characterizing hepatitis C." This invention provides novel methods and compositions for amplifying portions of the HCV genome. The nucleic acid sequences set forth as SEQ ID NOS:1-64 derived from HCV cDNA and functional equivalents thereof, kits containing the same, and methods employing the same, are useful for the identification and characterization of HCV in biological samples. She has 1 patent to her name.
Career Highlights
Throughout her career, Carol has been associated with Lab21, Inc., where she has applied her expertise in molecular biology and virology. Her work has been instrumental in advancing the understanding of hepatitis C, which affects millions of people worldwide.
Collaborations
[Section skipped due to space constraints.]
Conclusion
Carol Holland-Staley's contributions to hepatitis C research exemplify the impact of innovative thinking in the medical field. Her work continues to pave the way for advancements in the identification and treatment of this significant health issue.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile